You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

DAPSONE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for dapsone and what is the scope of freedom to operate?

Dapsone is the generic ingredient in two branded drugs marketed by Abbvie, Almirall, Alembic, Amneal, Cosette, Encube, Mylan, Padagis Israel, Taro, Torrent, Trupharma, Zydus Lifesciences, Actavis Llc, Alvogen, Chartwell Rx, Everest Life Sci, Nostrum Labs Inc, Novitium Pharma, and Rising, and is included in twenty-five NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Dapsone has twenty-three patent family members in fifteen countries.

There are eight drug master file entries for dapsone. Twenty-seven suppliers are listed for this compound.

Drug Prices for DAPSONE

See drug prices for DAPSONE

Recent Clinical Trials for DAPSONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
All India Institute of Medical Sciences, BhubaneswarPhase 4
Assiut UniversityPhase 4
Pulmonem Inc.Phase 3

See all DAPSONE clinical trials

Pharmacology for DAPSONE
Drug ClassSulfone
Medical Subject Heading (MeSH) Categories for DAPSONE
Paragraph IV (Patent) Challenges for DAPSONE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
ACZONE Gel dapsone 7.5% 207154 1 2017-02-13

US Patents and Regulatory Information for DAPSONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro DAPSONE dapsone GEL;TOPICAL 209506-001 Oct 16, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rising DAPSONE dapsone TABLET;ORAL 207165-002 Jul 20, 2023 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Novitium Pharma DAPSONE dapsone TABLET;ORAL 206505-002 Dec 1, 2016 AB RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for DAPSONE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie ACZONE dapsone GEL;TOPICAL 021794-001 Jul 7, 2005 ⤷  Sign Up ⤷  Sign Up
Almirall ACZONE dapsone GEL;TOPICAL 207154-001 Feb 24, 2016 ⤷  Sign Up ⤷  Sign Up
Almirall ACZONE dapsone GEL;TOPICAL 207154-001 Feb 24, 2016 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for DAPSONE

Country Patent Number Title Estimated Expiration
European Patent Office 2922528 COMPOSITIONS TOPIQUES DE DAPSONE ET DE DAPSONE/ADAPALÈNE ET LEURS MÉTHODES D'UTILISATION (TOPICAL DAPSONE AND DAPSONE/ADAPALENE COMPOSITIONS AND METHODS FOR USE THEREOF) ⤷  Sign Up
World Intellectual Property Organization (WIPO) 2014081674 ⤷  Sign Up
Russian Federation 2638815 КОМПОЗИЦИИ ДЛЯ МЕСТНОГО ПРИМЕНЕНИЯ, СОДЕРЖАЩИЕ ДАПСОН И ДАПСОН/АДАПАЛЕН, И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ (TOPICAL APPLICATION COMPOSITIONS CONTAINING DAPSON AND DAPSONE/ADAPALEN, AND METHODS FOR THEIR APPLICATION) ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.